Navigation path

Pharmaceuticals - Community Register

  

Community list of not active orphan medicinal products
WITHDRAWN  

Product information

N-carboxymethyl-glycyl-L-threonyl-L-histidyl-L-3,3-diphenylalanyl-L-piperidincarboxy-3-yl-L-arginyl-L-S-methylthio-cystyl-L-arginyl-L-tryptophyl-aminohexanyl-N-carboxamidomethyl-glycine N-hexadecylamide

EU orphan designation number: EU/3/16/1650
Active ingredient: N-carboxymethyl-glycyl-L-threonyl-L-histidyl-L-3,3-diphenylalanyl-L-piperidincarboxy-3-yl-L-arginyl-L-S-methylthio-cystyl-L-arginyl-L-tryptophyl-aminohexanyl-N-carboxamidomethyl-glycine N-hexadecylamide
Indication: Treatment of beta thalassaemia intermedia and major
Sponsor: QRC Consultants Ltd
Silvaco Technology Centre, Compass Point, St Ives, Cambridgeshire PE27 5JL, United Kingdom

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page
Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
03/05/2016 Orphan designation EMA/OD/242/15 (2016) 2728 of 28/04/2016
07/07/2017 Removal of orphan designation from Community Register